Skip to content

Evaluation of different potassium oxalate concentrations in teeth hypersensitivity

Clinical evaluation of different potassium oxalate concentrations in dentin hypersensitivity treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3pr9pp
Enrollment
Unknown
Registered
2017-08-07
Start date
2017-03-16
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatognathic diseases, tooth abrasion, dentin sensitivity, tooth erosion

Interventions

This study refers to a clinical follow-up, in which 32 subjects with dentin hypersensitivity in less than two teeth in different quadrants receive two types of desensitization protocols. Group 1: Prot
Drug

Sponsors

Hospital Odontológico da Universidade Federal de Uberlândia
Lead Sponsor
Universidade Federal de Uberlândia
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The criteria for inclusion of the patients will be: healthy individuals who are interested in the treatment of Dentin Hypersensitivity; Agree to participate and sign the informed consent form (TCLE); Patients with all teeth in their mouth; Patients with at least two teeth with Dentin Hypersensitivity in different quadrants.

Exclusion criteria

Exclusion criteria: The criteria for exclusion of patients will be: presence of dentin hypersensitivity caused due to the presence of caries or unsatisfactory restorations; Patients in orthodontic or periodontal treatment; Patients performing dental whitening; Presence of spontaneous pain in the tooth with dentin hypersensitivity, characterizing pulpitis; Presence of periodontal disease; Unsatisfactory oral hygiene; Use of extensive prostheses; Patients with severe bruxism and loss of vertical dimension; Patients with uncontrolled gastroesophageal reflux disease; Patients with uncontrolled systemic and / or psychological diseases; Pregnancy and smokers.

Design outcomes

Primary

MeasureTime frame
Reduction in dentin hypersensitivity in patients submitted to different concentration with twotypes of potassiun oxalate in 3 weeks follow-up. The evaluation will be carried out by visual analogy scale of pain from the observation of a range of at least 30% in the pre and post intervention measurements.

Secondary

MeasureTime frame
To determine an effective treatment protocol for reduction in dentin hypersensitivity, regarding the desensitizing agent concentration.The effectiveness evaluation will be carried out by visual analogy scale.

Countries

Brazil

Contacts

Public ContactPaulo Soares

Faculdade de Odontologia da Universidade Federal de Uberlândia - FOUFU

paulovsaores@yahoo.com.br+55(34)32258117

Outcome results

None listed

Source: REBEC (via WHO ICTRP)